Home / Conditions / Ibs-d
Ibs-d: when insurers say no, reviewers often say yes
In 23 published external-review decisions involving ibs-d, independent physician reviewers overturned the insurer’s denial 100% of the time.
Published decisions
23
2001–2026
Overturned
100%
23 denials reversed
Most-fought treatments for ibs-d
What insurers denied — and how those fights ended.
| Treatment | Decisions | Overturned |
|---|---|---|
| Xifaxan | 20 | 100% |
How to use this in your appeal
These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for ibs-d was denied, the published record says the denial is worth fighting.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.